Below are the most recent publications written about "Dependovirus" by people in Profiles.
-
Tang Q, Pires-Ferreira D, Mueller C, Gruntman AM, Flotte TR. Optimization of Alpha-1 Antitrypsin Expression from Adeno-Associated Virus Vectors. Hum Gene Ther. 2026 Jul; 37(13-14):609-617.
-
Wu HL, Webb GM, Fuchs SP, Pessoa CT, Hwang JM, Fisher HK, McCullen AJ, Humkey MC, Brown MK, Waytashek CM, Boyle CD, Kukula KA, Potter SK, Devlin G, Elmore ZC, Hull JA, Zikos J, Swanson T, Armantrout K, Chun K, Crank H, Bailey L, White R, Barber-Axthelm A, Fischer M, Smedley JV, Axthelm MK, Fennessey CM, Keele BF, Desrosiers RC, Magnani DM, Asokan A, Sacha JB. Adeno-associated virus gene therapy-mediated CCR5 blockade suppresses virus replication long term in SHIV-infected macaques. Sci Transl Med. 2026 Apr 29; 18(847):eadw1976.
-
Xicluna R, Yamada K, Gonzalez-Visiedos M, Greenwood CM, Zaugg D, Waiz D, Steiner G, Hahn K, Schwandt T, Otteneder MB, Biswas M, Mu?oz-Melero M, Kumar SRP, Herzog RW, Haegel H. Transient prophylactic immunosuppression with abatacept or dasatinib prevents immune responses in AAV gene transfer. Mol Ther. 2026 Jul 01; 34(7):3805-3819.
-
Parajuli S, Gallagher T, Flotte TR. Immune Toxicities in AAV Gene Therapy: Overview for Clinicians. Int J Mol Sci. 2026 Mar 31; 27(7).
-
Saylam E, D'ambrosio ES, Pesco MT, Gushchina LV. Adeno-Associated Virus Toxicity in Duchenne Muscular Dystrophy: Mechanisms and Clinical Considerations. Genes (Basel). 2026 Feb 27; 17(3).
-
Tang JH, Taghian T, Jayakumar S, Parigi G, Luchinat C, Hall E, Gray-Edwards HL, Meade TJ. Bioresponsive MR Imaging Probes for Noninvasive Monitoring of AAV Gene Therapy. Bioconjug Chem. 2026 Mar 18; 37(3):545-552.
-
Lewis CJ, D'Souza P, Johnston JM, Acosta MT, Farmer C, Baker EH, Crowell A, Mojica Y, Ashraf S, Joseph L, V?zina G, Quezado Z, Yousef MH, Vardar Z, Shazeeb MS, Corti M, Blackwood M, Coleman K, Batista R, Thurm A, De Boever E, Gahl WA, Byrne BJ, Flotte TR, Jiang X, Gross AL, Keeler AM, Gray-Edwards H, Martin DR, Sena-Esteves M, Tifft CJ. AAV9 Gene Therapy in Type II GM1 Gangliosidosis - A Phase 1-2 Trial. N Engl J Med. 2026 Mar 26; 394(12):1184-1194.
-
Cui M, Cheng SY, Liang J, McGowan J, Xu M, Xu G, Luo L, Wu J, Harman CD, Jacobson AL, Kapeller LE, Mayes MA, Namkung S, Sharma T, Leland TB, Zhang F, Yip M, Rossmiller B, Xue T, Chen X, Boonying W, Lotun A, Wang D, Su Q, Xie J, Wei Y, Rothstein AM, Gregory-Ksander MS, Komaromy A, Tian B, Lin H, Punzo C, Tai PWL, Gao G. Modification of the VP1u region boosts transduction of adeno-associated virus vectors for ocular gene therapy. Mol Ther. 2026 May 06; 34(5):2781-2800.
-
Pola-V?liz V, Arredondo SB, Arancibia Y, Ahumada J, Estay S, Vidal N, Haeger PA, Fuenzalida M, Varela-Nallar L, Bustos FJ, Montecino M, van Zundert B. Viral-mediated fluorescent labelling of activated hippocampal memory engrams to study epigenetic dynamics associated with gene expression. Methods. 2026 Mar; 247:85-94.
-
Hoyle B, Bello D, Hill J, Das S, Kim J. Imaged Capillary Isoelectric Focusing (icIEF) Platform for Characterization of Charge Variants of Adeno-Associated Virus (AAV) Capsids and Impact on their Transduction Efficiency. Curr Gene Ther. 2026; 26(2):1-16.